Sarah Walinsky, JD
Acting Chief of Staff, FDA CBER
In February 2022 circulated Dr. Szarfman's preprint on masking to FDA officials weighing Moderna's pediatric COVID-19 vaccine appeal.
Timeline appearances (1)
- publication
Walinsky circulates Szarfman's preprint to FDA officials weighing Moderna's pediatric COVID-19 vaccine appeal.